<DOC>
	<DOCNO>NCT02712736</DOCNO>
	<brief_summary>The purpose study ass healthcare-related quality life ( HRQOL ) , impact risk liver transplant risk malignancy HRQOL , complementary alternative medicine use patient PSC .</brief_summary>
	<brief_title>Quality Life Patients With Primary Sclerosing Cholangitis</brief_title>
	<detailed_description>A cohort adult ( age ≥ 18 ) patient diagnosis PSC identify . The patient approach participate study appointment , either investigator someone else know patient . If patient agrees , investigator key personnel provide information study obtain informed consent participate . The patient consent participate send home clinic survey complete return via mail provide addressed , stamp envelope . The survey consist Short Form-36 ( SF-36 ) , Chronic Liver Disease Questionnaire ( CLDQ ) , question PROMIS SexFs v2.0 , question regard perceive risk liver transplant , cholangiocarcinoma , colorectal carcinoma , well perceive overall life expectancy , question regard complementary alternative medicine use . Demographic information clinical data also obtain patient 's electronic medical record . The study cross-sectional nature , follow-up subject survey complete .</detailed_description>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>Adult ( age ≥ 18 ) patient PSC , confirm laboratory test , image , and/or liver biopsy Patients &lt; 18 Patients undergone liver transplant , patient frank hepatic encephalopathy Patients active inflammatory bowel disease ( IBD ) flare Patients malignancy Patients unable understand English Patients refuse participate provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Primary Sclerosing Cholangitis</keyword>
</DOC>